Emalex Biosciences received a patent covering an orally disintegrating tablet (ODT) formulation of ecopipam, an ...

COSMETIC botulinum toxin type A may trigger serum sickness, widening concern about delayed systemic hypersensitivity reactions. Se ...

Following the abolishment of Healthwatch, we explore what must be considered when designing what comes next for patient voice ...

Driven by innovation in zero-sugar formulations, functional ingredients, and premium sourcing, these leading brands are ...

Under the new priority voucher program (CNPV), the FDA has approved a new oral GLP-1 drug, Foundayo, offering an alternative ...

The beauty manufacturer is transforming beauty with microfluidic innovation, powering breakthrough formulations for luxury clients like Chanel.

Using patent intelligence data from the FounderNest platform, alongside funding, partnership, and deployment signals across ...

It needs to be pointed out here that the mission-oriented approach adopted by Pakistan on the foreign policy front allowed ...

On March 20, Delhi HC in an interim decision allowed the sale of the generic formulation. The final verdict will have far-reaching consequences on the way an originator can build moats to delay generi ...

A recent case report has highlighted a rare but clinically significant immune complication—serum sickness—following cosmetic ...

This weekend, Donald Trump has begun to say the quiet part out loud -- that he wants to take control of Iran's oil, a ...

A 2026 informational report on Black Wood Tea ingredients, the venous leakage erectile dysfunction concept, Johns Hopkins ...